Transcriptomic Analysis of Identical Twins with ALD and Different Onset Ages

Yinglian Chen, Chuhua Fu, Yonghui Zhang, Yan Zhang, Ying Cao, Xinggang Wang, Zhiming Zeng, Chen Liu, Changlin Yin, Liang TanResearch Square 2024 · DOI

Abstract

Background: Adrenoleukodystrophy (ALD) is a rare X-linked neurogenetic disease caused by mutations in the ABCD1 gene. Currently, the molecular mechanisms underlying the onset and severity of ALD still remain unclear. Therefore, the aim of this paper is to mine information on candidate genes associated with onset and severity of ALD by transcriptome sequencing of whole blood samples from monozygotic twin families with ALD disease. Method: The identifying of differentially expressed genes (DEGs), set theory analysis, gene enrichment analysis, and classification statistics of expression trend had been executed to identify potential candidate genes inducing the onset and severity of ALD in patients. And, eight ALD patients, which constituted by two normal children, two ALD child twins, twins’ mother, twins’ adult uncle with ALD, twins’ grandmother, and a normal adult had been used. Result: In the present, five distinct sets of differentially expressed genes (DEGs) were identified via using whole blood samples from a family of identical twins with different onset ages and ABCD1 exon 2 deletion. Then, 39 DEGs of A∩B∩C-D and A∩B-D as well as 425 DEGs of C∩E had been considered as relating genes with the onset and severity of ALD. Especially, C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, and LRRC69 had shown more important than others about ALD onset. Meanwhile, KEGG and GO enrichment further suggested the role of Ca2+ homeostasis and plasma membrane for ALD onset and severity. Finally, expression pattern analysis further demonstrated the pivotal role of the selected DEG sets. Conclusion: The information on candidate genes of this research had been considered as the crucial for preliminarily exploring the molecular mechanisms relating to the onset and severity of ALD, which offered novel insights and research directions for mitigating and treating the development of ALD.

Introduction

X-linked adrenoleukodystrophy (ALD) is a rare neurogenetic disorder caused by mutations in the ABCD1 gene, which disrupts the metabolism of very long-chain fatty acids (VLCFAs). This leads to devastating damage to the adrenal glands and brain white matter. The central mystery of ALD is its extreme phenotypic variability: individuals with the exact same genetic mutation can have wildly different outcomes, ranging from being completely asymptomatic to suffering rapid neurological decline in childhood. Even identical twins can show different onset ages. This "genotype-phenotype gap" makes it nearly impossible to predict disease progression or time interventions effectively. This paper seeks to identify the "modifier" genes and molecular pathways that determine when and why the disease actually starts.

Methods

The researchers utilized a rare clinical opportunity: a family containing identical twin boys who both carry a homozygous deletion in exon 2 of the ABCD1 gene, but only one of whom has developed symptoms.

Study Cohort

Transcriptome sequencing (RNA-seq) was performed on whole blood samples from eight individuals from a single family lineage. This included the twins, their mother and grandmother (carriers), an asymptomatic homozygous male (uncle), and three healthy controls.

Table 1: Clinical and genetic characteristics of the eight study participants.

Bioinformatics Pipeline

To isolate genes specifically related to onset rather than just the mutation, the researchers used set theory analysis involving five different comparative groups. Standard R packages were used for visualization, and the Mfuzz package was employed for soft clustering to categorize genes based on expression trends across clinical states (Normal → Asymptomatic Carrier → Symptomatic).

Table 2: Comparative groups used to define the five sets of differentially expressed genes (DEGs).

Results

The study identified 39 DEGs associated with the onset of ALD and 425 DEGs associated with pathological progression (the "execution" set).

Onset vs. Execution Gene Sets

The authors distinguished between genes that likely induce the disease (found in the intersection of the twins and the asymptomatic uncle) and genes that represent the pathological effect of the disease once it has started. Seven genes—C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26, and LRRC69—emerged as critical candidates. Notably, SMAD1 is involved in nervous system development, and IL-26 is a known inflammatory factor, providing a link between metabolic defects and neuroinflammation.

Pathway Enrichment

The most significant finding was the enrichment of genes related to $Ca^{2+}$ homeostasis and plasma membrane stability. Previous studies suggested VLCFA accumulation disrupts membranes; this paper provides transcriptomic evidence that these specific pathways are where the "breakdown" occurs during onset. Top biological processes identified included cell-cell signaling, sodium ion transport, and positive regulation of the MAPK cascade.

Discussion and Conclusion

While the study provides valuable insights, it is limited by a small sample size (n=8) and the use of whole blood samples as a proxy for brain tissue. Future work must include functional validation through qPCR, Western Blotting, and gene knockdown experiments in cell lines or animal models.

In conclusion, the identification of candidate genes related to calcium homeostasis and membrane stability offers novel insights into the molecular mechanisms of ALD onset and severity. These findings provide a foundation for future research aimed at mitigating and treating the development of this rare neurogenetic disease.

Summary updated

Abstract

<title>Abstract</title> Background Adrenoleukodystrophy (ALD) is a rare X-linked neurogenetic disease caused by mutations in the <italic>ABCD1</italic> gene. Currently, the molecular mechanisms underlying the onset and severity of ALD still remain unclear. Therefore, the aim of this paper is to mine information on candidate genes associated with onset and severity of ALD by transcriptome sequencing of whole blood samples from monozygotic twin families with ALD disease. Method The identifying of differentially expressed genes (DEGs), set theory analysis, gene enrichment analysis, and classification statistics of expression trend had been executed to identify potential candidate genes inducing the onset and severity of ALD in patients. And, eight ALD patients, which constituted by two normal children, two ALD child twins, twins’ mother, twins’ adult uncle with ALD, twins’ grandmother, and a normal adult had been used. Result In the present, five distinct sets of differentially expressed genes (DEGs) were identified via using whole blood samples from a family of identical twins with different onset ages and <italic>ABCD1</italic> exon 2 deletion. Then, 39 DEGs of A∩B∩C-D and A∩B-D as well as 425 DEGs of C∩E had been considered as relating genes with the onset and severity of ALD. Especially, <italic>C4BPA, TPBG, CEP112, CHST15, SMAD1, IL-26</italic>, and <italic>LRRC69</italic> had shown more important than others about ALD onset. Meanwhile, KEGG and GO enrichment further suggested the role of Ca<sup>2+</sup> homeostasis and plasma membrane for ALD onset and severity. Finally, expression pattern analysis further demonstrated the pivotal role of the selected DEG sets. Conclusion The information on candidate genes of this research had been considered as the crucial for preliminarily exploring the molecular mechanisms relating to the onset and severity of ALD, which offered novel insights and research directions for mitigating and treating the development of ALD.
BibTeX
@inproceedings{chen2024transcriptomic,
  author = {Yinglian Chen and Chuhua Fu and Yonghui Zhang and Yan Zhang and Ying Cao and Xinggang Wang and Zhiming Zeng and Chen Liu and Changlin Yin and Liang Tan},
  title = {{Transcriptomic Analysis of Identical Twins with ALD and Different Onset Ages}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-4938524/v1},
}
Figure